Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) has been closed on 07 May 2025.
It no longer accepts any bids. For further information,
you can contact the National Institutes of Health
Bellow, you can find more information about this project:
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.